Odal METastasis in high risk Endometrial Cancer (NOMETEC): detection methods and the prevalence of lymph node micrometastasis - NOMETEC

Diakonessenhuis Utrecht0 个研究点目标入组 290 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•This study is a multicenter cross-sectional diagnostic invention study, consisting of two sub-studies. ;Inclusion criteria PART I:
•====================;All women, undergoing a hysteroscopic curettage and a hysterectomy because of suspicion for a (malignant) lesion of the endometrium.;Inclusion criteria PART II:
•====================;Only patients with high risk endometrial cancer will be included in this study, because - according to the recently revised national guideline - standard care in these patients includes a pelvic and para-aortal lymphadenctomy. High risk patients are defined as having at least one of the following characteristics: differentiation grade 3, > 50% myometrial invasion, suspicious for extra-corporal spread, high risk histological type (serous papillary, clear cell or carcinosarcoma tumour type)

•Exclusion criteria PART I and PART II:
•==============================;Patients with contraindications for open abdominal or laparoscopic surgery will be excluded: cervical or pelvic infection, severe cardio-pulmonal or other co-morbidity contra-indicating extensive surgery and anaesthesia.

发起方